Yigal Nochomovitz Score: 24
Analyst at
Summit Redstone Partners,
Citigroup
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-23.5%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
20%
2 W / 8 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
4 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
13%
1 W / 7 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
13%
1 W / 7 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
11%
1 W / 8 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
20%
2 W / 8 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 26, 2025 |
Summit Therapeutics Inc
SMMT
|
BUY |
$35.00
Est. +76%
|
$19.89 | $36.91 |
Target Met
|
$14.01
-29.6%
|
| Oct 24, 2024 |
Arcus Biosciences Inc
RCUS
|
BUY |
$46.00
Est. +164%
|
$17.42 | $18.98 |
Miss
|
$23.80
+36.6%
|
| Sep 27, 2024 |
Summit Therapeutics Inc
SMMT
|
BUY |
$23.00
Est. +10%
|
$20.89 | $36.91 |
Target Met
|
$14.01
-32.9%
|
| Sep 10, 2024 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$36.00
Est. +29%
|
$27.93 | $36.20 |
Bullseye Hit (±1%)
|
$30.54
+9.3%
|
| Aug 27, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$58.00
Est. +46%
|
$39.80 | $40.25 |
Miss
|
$28.98
-27.2%
|
| Aug 15, 2024 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$34.00
Est. +69%
|
$20.09 | $22.50 |
Miss
|
$18.25
-9.2%
|
| Aug 15, 2024 |
Shattuck Labs Inc
STTK
|
BUY |
$8.00
Est. +156%
|
$3.12 | $3.95 |
Miss
|
$4.94
+58.3%
|
| Aug 15, 2024 |
LENZ Therapeutics Inc.
LENZ
|
BUY |
$32.00
Est. +36%
|
$23.50 | $41.70 |
Target Met
|
$6.77
-71.2%
|
| Nov 08, 2021 |
Fate Therapeutics Inc
FATE
|
BUY |
$87.00
Est. +43%
|
$60.79 | - | - |
$2.06
-96.6%
|
| Nov 03, 2021 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$150.00
Est. +74%
|
$86.00 | - | - |
$24.35
-71.7%
|
Summit Therapeutics Inc
SMMT
Mar 26, 2025
Signal & Target
BUY
$35.00
Start Price
$19.89
Best Price (1Y)
$36.91
Current Price
$14.01
Return
-29.6%
Arcus Biosciences Inc
RCUS
Oct 24, 2024
Signal & Target
BUY
$46.00
Start Price
$17.42
Best Price (1Y)
$18.98
Current Price
$23.80
Return
+36.6%
Summit Therapeutics Inc
SMMT
Sep 27, 2024
Signal & Target
BUY
$23.00
Start Price
$20.89
Best Price (1Y)
$36.91
Current Price
$14.01
Return
-32.9%
ArriVent BioPharma Inc.
AVBP
Sep 10, 2024
Signal & Target
BUY
$36.00
Start Price
$27.93
Best Price (1Y)
$36.20
Current Price
$30.54
Return
+9.3%
Ideaya Biosciences Inc
IDYA
Aug 27, 2024
Signal & Target
BUY
$58.00
Start Price
$39.80
Best Price (1Y)
$40.25
Current Price
$28.98
Return
-27.2%
Syndax Pharmaceuticals Inc
SNDX
Aug 15, 2024
Signal & Target
BUY
$34.00
Start Price
$20.09
Best Price (1Y)
$22.50
Current Price
$18.25
Return
-9.2%
Shattuck Labs Inc
STTK
Aug 15, 2024
Signal & Target
BUY
$8.00
Start Price
$3.12
Best Price (1Y)
$3.95
Current Price
$4.94
Return
+58.3%
LENZ Therapeutics Inc.
LENZ
Aug 15, 2024
Signal & Target
BUY
$32.00
Start Price
$23.50
Best Price (1Y)
$41.70
Current Price
$6.77
Return
-71.2%
Fate Therapeutics Inc
FATE
Nov 08, 2021
Signal & Target
BUY
$87.00
Start Price
$60.79
Best Price (1Y)
-
Current Price
$2.06
Return
-96.6%
Ultragenyx Pharmaceutical Inc.
RARE
Nov 03, 2021
Signal & Target
BUY
$150.00
Start Price
$86.00
Best Price (1Y)
-
Current Price
$24.35
Return
-71.7%